NCT05397626

Brief Summary

The aim of this 10-week pilot study is to explore the potential benefit of two recently developed non-invasive interventions, heart rate variability biofeedback (HRV-BF) and OTC supplement hydrogen water, for the symptoms of chronic fatigue syndrome (CFS). Symptom measures and heart monitoring information will be generated by this study. Given the lack of effective treatments in this illness, these two non-invasive home-based treatments may help patients feel and function better.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
39

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started May 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 23, 2022

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

May 25, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 31, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 23, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 23, 2023

Completed
Last Updated

May 31, 2022

Status Verified

May 1, 2022

Enrollment Period

1 year

First QC Date

May 25, 2022

Last Update Submit

May 25, 2022

Conditions

Keywords

Heart Rhythm Biofeedback; Hydrogen Water

Outcome Measures

Primary Outcomes (1)

  • Fatigue Severity Scale

    self-report measure of fatigue impact on functioning.Minimum value=1; Maximum value=7; Range: 1.00-7.00. High scores indicate more sever fatigue and a worse outcome.

    8 weeks

Secondary Outcomes (3)

  • Short Form-36 Physical Function Subscale

    8 weeks

  • Depression, Anxiety and Stress Scale

    8 weeks

  • Brief Resilience Scale

    8 weeks

Study Arms (3)

Heart Rhythm Biofeedback

ACTIVE COMPARATOR

Heart rhythm biofeedback is a non-invasive physiological treatment that is administered via an app downloaded to personal smart phones. It involves participants attaching a wireless sensor to the ear that monitors heart rate that is displayed on the phone screen app. The participant is actively involved in modifying the heart biofeedback to achieve optimal levels of heart rate variability, an established indicator of health and well-being and a potential factor in chronic fatigue syndrome. The treatment lasts 8 weeks.

Dietary Supplement: Hydrogen WaterCombination Product: Combined treatment: Heart rhythm biofeedback plus hydrogen water

Hydrogen Water

ACTIVE COMPARATOR

Hydrogen pills are mixed in a water glass that is ingested up to 3 times a day for 8 weeks. The hydrogen supplement is intended to reduce oxidative stress and inflammation both of which are implicated in the pathophysiology of chronic fatigue syndrome. This is an 8 week treatment.

Behavioral: Heart Rhythm BiofeedbackCombination Product: Combined treatment: Heart rhythm biofeedback plus hydrogen water

Combined treatment: Heart rhythm biofeedback plus hydrogen water

ACTIVE COMPARATOR

This condition combines heart rhythm biofeedback and hydrogen water, as described above, which is intended to assess any additive or synergistic effects of the two treatments. This is an 8 week treatment.

Behavioral: Heart Rhythm BiofeedbackDietary Supplement: Hydrogen Water

Interventions

Heart rhythm biofeedback is a non-invasive intervention intended to improve heart rate variability and physical resilience that is often limited in chronic fatigue syndrome

Combined treatment: Heart rhythm biofeedback plus hydrogen waterHydrogen Water
Hydrogen WaterDIETARY_SUPPLEMENT

Hydrogen water, if ingested daily over several weeks, may have antioxidant and anti-inflammatory effects in chronic fatigue syndrome

Combined treatment: Heart rhythm biofeedback plus hydrogen waterHeart Rhythm Biofeedback

This treatment is intended to explore the possible additive or synergistic effects of combining heart rhythm biofeedback and hydrogen water.

Heart Rhythm BiofeedbackHydrogen Water

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of chronic fatigue, chronic fatigue syndrome, or something similar. ages 18-65. - BMI\>30.

You may not qualify if:

  • Other major medical condition or regular medication that produces fatigue. No home computer or internet access. No smart phone.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fred Friedberg

Stony Brook, New York, 11794, United States

RECRUITING

MeSH Terms

Conditions

Fatigue Syndrome, Chronic

Interventions

Water

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesEncephalomyelitisNeuroinflammatory DiseasesNervous System DiseasesNeuromuscular DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

HydroxidesAlkaliesInorganic ChemicalsAnionsIonsElectrolytesOxidesOxygen Compounds

Study Officials

  • FRED FRIEDBERG, Phd

    Stony Brook University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Daniel Gordon, BA

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Each participant fill out online outcome forms that involve no interaction with the principal investigator or study staff, thus avoiding any staff-specific influence on online outcome forms.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This clinical study involves three active intervention groups: group 1 receiving heart rhythm biofeedback alone, group receiving hydrogen water alone, and group 3 receiving both heart rhythm biofeedback and hydrogen water.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 25, 2022

First Posted

May 31, 2022

Study Start

May 23, 2022

Primary Completion

May 23, 2023

Study Completion

May 23, 2023

Last Updated

May 31, 2022

Record last verified: 2022-05

Locations